{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T06:24:57Z","timestamp":1793514297047,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Caisse Nationale d\u2019Assurance Maladie"},{"DOI":"10.13039\/501100004571","name":"Minist\u00e8re des Affaires Sociales et de la Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004571","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004792","name":"Minist\u00e8re de l'Enseignement Sup\u00e9rieur et de la Recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-025-04213-0","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T10:04:11Z","timestamp":1751364251000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Prevalence of chronic kidney disease in France - The constances cohort"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4860-4279","authenticated-orcid":false,"given":"Jacques","family":"Blacher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofiane","family":"Kab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynda","family":"Cheddani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Halimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9n\u00e9dicte","family":"Stengel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia Alencar","family":"De Pinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Zins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Oli\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"4213_CR1","doi-asserted-by":"crossref","unstructured":"Levey AS, Eckardt KU, Dorman NM, Christiansen SL, Hoorn EJ, Ingelfinger JR, et al. Nomenclature for kidney function and disease: Report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference. Kidney Int. 2020;97(6):1117\u201329.","DOI":"10.1159\/000509359"},{"key":"4213_CR2","unstructured":"Agence de la biom\u00e9decine. Rapport Annuel 2018 R\u00e9seau Epid\u00e9miologie et Information en N\u00e9phrologie [Internet]. 2020. Available from: https:\/\/www.agence-biomedecine.fr\/IMG\/pdf\/rapport_rein_2018_v2.pdf"},{"key":"4213_CR3","doi-asserted-by":"publisher","unstructured":"Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296\u2013305. https:\/\/doi.org\/10.1056\/NEJMoa041031. Erratum in: N Engl J Med. 2008;18(4):4. PMID: 15385656.","DOI":"10.1056\/NEJMoa041031"},{"issue":"6","key":"4213_CR4","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1053\/j.ajkd.2019.08.026","volume":"75","author":"K Legrand","year":"2020","unstructured":"Legrand K, Speyer E, Stengel B, Frimat L, Ngueyon Sime W, et al. Perceived health and quality of life in patients with CKD, including those with kidney failure: Findings from national surveys in France. Am J Kidney Dis. 2020;75(6):868\u201378.","journal-title":"Am J Kidney Dis"},{"key":"4213_CR5","doi-asserted-by":"publisher","unstructured":"Stengel B, Metzger M, Combe C, Jacquelinet C, Brian\u00e7on S, Ayav C, et al. Risk profile, quality of life and care of patients with moderate and advanced CKD: The French CKD-REIN Cohort Study. Nephrol Dial Transplant. 2019;34(2):277\u2013286. https:\/\/doi.org\/10.1093\/ndt\/gfy058. PMID: 29635335.","DOI":"10.1093\/ndt\/gfy058"},{"key":"4213_CR6","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1186\/1471-2458-10-479","volume":"10","author":"M Zins","year":"2010","unstructured":"Zins M, Bonenfant S, Carton M, Coeuret-Pellicer M, Gu\u00e9guen A, Gourmelen J, et al. The CONSTANCES cohort: An open epidemiological laboratory. BMC Public Health. 2010;10:479. https:\/\/doi.org\/10.1186\/1471-2458-10-479. PMID: 20704723; PMCID: PMC2927544.","journal-title":"BMC Public Health"},{"issue":"12","key":"4213_CR7","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1007\/s10654-015-0096-4","volume":"30","author":"CONSTANCES team","year":"2015","unstructured":"CONSTANCES team, Zins M, Goldberg M. The French CONSTANCES population-based cohort: Design, inclusion and follow-up. Eur J Epidemiol. 2015;30(12):1317\u201328.","journal-title":"Eur J Epidemiol"},{"issue":"1","key":"4213_CR8","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1186\/s12889-016-3439-5","volume":"16","author":"F Ruiz","year":"2016","unstructured":"Ruiz F, Goldberg M, Lemonnier S, Ozguler A, Boos E, Brigand A, et al. High quality standards for a large-scale prospective population-based observational cohort: Constances. BMC Public Health. 2016;16(1):877. https:\/\/doi.org\/10.1186\/s12889-016-3439-5. PMID: 27557750; PMCID: PMC4997774.","journal-title":"BMC Public Health"},{"key":"4213_CR9","doi-asserted-by":"crossref","unstructured":"Schneider SL. The International Standard Classification of Education 2011. In: Birkelund GE, editor. Class and stratification analysis (comparative social research, volume 30). Bingley, UK: Emerald Group Publishing Limited; 2013. pp. 365\u2013379.","DOI":"10.1108\/S0195-6310(2013)0000030017"},{"key":"4213_CR10","doi-asserted-by":"publisher","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604\u201312. https:\/\/doi.org\/10.7326\/0003-4819-150-9-200905050-00006. Erratum in: Ann Intern Med. 2011;155(6):408. PMID: 19414839; PMCID: PMC2763564.","DOI":"10.7326\/0003-4819-150-9-200905050-00006"},{"key":"4213_CR11","doi-asserted-by":"publisher","unstructured":"Bongard V, Dallongeville J, Arveiler D, Ruidavets JB, Cottel D, Wagner A, et al. Estimation et caract\u00e9risation de l\u2019insuffisance r\u00e9nale chronique en France [Assessment and characteristics of chronic renal insufficiency in France]. Ann Cardiol Angeiol (Paris). 2012;61(4):239\u201344. French. https:\/\/doi.org\/10.1016\/j.ancard.2012.03.003. Epub 2012 Mar 23. PMID: 22503754.","DOI":"10.1016\/j.ancard.2012.03.003"},{"issue":"7","key":"4213_CR12","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.nephro.2021.05.006","volume":"17","author":"V Oli\u00e9","year":"2021","unstructured":"Oli\u00e9 V, Cheddani L, Stengel B, Gabet A, Grave C, Blacher J, et al. Pr\u00e9valence de La maladie R\u00e9nale chronique En france, Esteban 2014\u20132016 [Prevalence of chronic kidney disease in france, Esteban study 2014\u20132016]. Nephrol Ther. 2021;17(7):526\u201331. French. https:\/\/doi.org\/10.1016\/j.nephro.2021.05.006. Epub 2021 Oct 8. PMID: 34629319.","journal-title":"Nephrol Ther"},{"issue":"9","key":"4213_CR13","doi-asserted-by":"publisher","first-page":"E417","DOI":"10.1503\/cmaj.120833","volume":"185","author":"P Arora","year":"2013","unstructured":"Arora P, Vasa P, Brenner D, Iglar K, McFarlane P, Morrison H, et al. Prevalence estimates of chronic kidney disease in canada: results of a nationally representative survey. CMAJ. 2013;185(9):E417\u201323. https:\/\/doi.org\/10.1503\/cmaj.120833. Epub 2013 May 6. PMID: 23649413; PMCID: PMC3680588.","journal-title":"CMAJ"},{"issue":"2","key":"4213_CR14","doi-asserted-by":"publisher","first-page":"e0118676","DOI":"10.1371\/journal.pone.0118676","volume":"10","author":"SD Fraser","year":"2015","unstructured":"Fraser SD, Aitken G, Taal MW, Mindell JS, Moon G, Day J, et al. Exploration of chronic kidney disease prevalence estimates using new measures of kidney function in the health survey for England. PLoS One. 2015;10(2):e0118676. https:\/\/doi.org\/10.1371\/journal.pone.0118676. PMID: 25700182; PMCID: PMC4336286.","journal-title":"PLoS ONE"},{"issue":"13","key":"4213_CR15","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1001\/jama.2023.17002","volume":"330","author":"ME Grams","year":"2023","unstructured":"Writing Group for the CKD Prognosis Consortium, Grams ME, Coresh J, Matsushita K, et al. Estimated glomerular filtration rate, albuminuria, and adverse outcomes: An individual-participant data meta-analysis. JAMA. 2023;330(13):1266\u201377. https:\/\/doi.org\/10.1001\/jama.2023.17002. PMID: 37787795; PMCID: PMC10548311.","journal-title":"JAMA"},{"issue":"7","key":"4213_CR16","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1681\/ASN.2015050542","volume":"27","author":"K Br\u00fcck","year":"2016","unstructured":"Br\u00fcck K, Stel VS, Gambaro G, Hallan S, V\u00f6lzke H, \u00c4rnl\u00f6v J, European CKD, Burden Consortium, et al. CKD prevalence varies across the European general population. J Am Soc Nephrol. 2016;27(7):2135\u201347. https:\/\/doi.org\/10.1681\/ASN.2015050542. Epub 2015 Dec 23. PMID: 26701975; PMCID: PMC4926978.","journal-title":"J Am Soc Nephrol"},{"key":"4213_CR17","doi-asserted-by":"publisher","unstructured":"Carrero JJ, Hecking M, Chesnaye NC, Jager KJ. Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease. Nat Rev Nephrol. 2018;14(3):151\u2013164. https:\/\/doi.org\/10.1038\/nrneph.2017.181. Epub 2018 Jan 22. PMID: 29355169.","DOI":"10.1038\/nrneph.2017.181"},{"key":"4213_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2015.230","author":"KT Mills","year":"2015","unstructured":"Mills KT, Xu Y, Zhang W, Bundy JD, Chen CS, Kelly TN, et al. A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010. Kidney Int. 2015;88(5):950\u20137. https:\/\/doi.org\/10.1038\/ki.2015.230. Epub 2015 Jul 29. PMID: 26221752; PMCID: PMC4653075."},{"issue":"9","key":"4213_CR19","doi-asserted-by":"publisher","first-page":"e10266","DOI":"10.7759\/cureus.10266","volume":"12","author":"J Qui\u00f1ones","year":"2020","unstructured":"Qui\u00f1ones J, Hammad Z. Social determinants of health and chronic kidney disease. Cureus. 2020;12(9):e10266. https:\/\/doi.org\/10.7759\/cureus.10266. PMID: 33042704; PMCID: PMC7537483.","journal-title":"Cureus"},{"issue":"2","key":"4213_CR20","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1053\/j.ajkd.2011.05.004","volume":"58","author":"CM Lora","year":"2011","unstructured":"Lora CM, Gordon EJ, Sharp LK, Fischer MJ, Gerber BS, Lash JP. Progression of CKD in hispanics: Potential roles of health literacy, acculturation, and social support. Am J Kidney Dis. 2011;58(2):282\u201390. https:\/\/doi.org\/10.1053\/j.ajkd.2011.05.004. PMID: 21787982; PMCID: PMC3144398.","journal-title":"Am J Kidney Dis"},{"issue":"21","key":"4213_CR21","doi-asserted-by":"publisher","first-page":"7026","DOI":"10.3390\/ijerph20217026","volume":"20","author":"J Diaz-Martinez","year":"2023","unstructured":"Diaz-Martinez J, Kallus L, Levine HM, Lavernia F, Pierre AJ, Mancilla J, et al. Community-engaged research (CEnR) to address gaps in chronic kidney disease education among underserved Latines-The CARE study. Int J Environ Res Public Health. 2023;20(21):7026. https:\/\/doi.org\/10.3390\/ijerph20217026. PMID: 37947582; PMCID: PMC10649949.","journal-title":"Int J Environ Res Public Health"},{"issue":"10407","key":"4213_CR22","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/S0140-6736(23)00876-0","volume":"402","author":"D van Mil","year":"2023","unstructured":"van Mil D, Kieneker LM, Evers-Roeten B, Thelen MHM, de Vries H, Hemmelder MH, et al. Participation rate and yield of two home-based screening methods to detect increased albuminuria in the general population in the Netherlands (THOMAS): A prospective, randomised, open-label implementation study. Lancet. 2023;402(10407):1052\u201364. https:\/\/doi.org\/10.1016\/S0140-6736(23)00876-0. Epub 2023 Aug 16. PMID: 37597522.","journal-title":"Lancet"},{"issue":"9731","key":"4213_CR23","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","volume":"375","author":"K Matsushita","year":"2010","unstructured":"Chronic Kidney Disease Prognosis Consortium, Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: A collaborative meta-analysis. Lancet. 2010;375(9731):2073\u201381. https:\/\/doi.org\/10.1016\/S0140-6736(10)60674-5. Epub 2010 May 17. PMID: 20483451; PMCID: PMC3993088.","journal-title":"Lancet"},{"key":"4213_CR24","doi-asserted-by":"publisher","unstructured":"Zelniker TA, Wiviott SD, Raz I, Im K, Goodrich EL, Bonaca MP, et al. SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: A systematic review and meta-analysis of cardiovascular outcome trials. Lancet. 2019;393(10166):31\u201339. https:\/\/doi.org\/10.1016\/S0140-6736(18)32590-X. Epub 2018 Nov 10. Erratum in: Lancet. 2019;393(10166):30.","DOI":"10.1016\/S0140-6736(18)32590-X"},{"key":"4213_CR25","doi-asserted-by":"publisher","unstructured":"Braunwald E. Gliflozins in the management of cardiovascular disease. N Engl J Med. 2022;386(21):2024\u20132034. https:\/\/doi.org\/10.1056\/NEJMra2115011. PMID: 35613023.","DOI":"10.1056\/NEJMra2115011"},{"issue":"6","key":"4213_CR26","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1053\/j.ajkd.2024.05.007","volume":"84","author":"MK Sullivan","year":"2024","unstructured":"Sullivan MK, Lees JS, Rosales BM, Cutting R, Wyld ML, Woodward M, et al. Sex and the relationship between cardiometabolic risk factors and estimated GFR decline: A population-based cohort study. Am J Kidney Dis. 2024;84(6):731\u2013e7411. https:\/\/doi.org\/10.1053\/j.ajkd.2024.05.007. Epub 2024 Jul 23. PMID: 39053834.","journal-title":"Am J Kidney Dis"},{"key":"4213_CR27","unstructured":"Santin G, Herquelot E, Gu\u00e9guen A, Carton M, Cyr D, Genreau M, et al. Estimation de pr\u00e9valences dans constances: premi\u00e8res explorations. Bull Epid\u00e9miol Hebd 2016;(35\u201336):622\u20139. http:\/\/invs.santepubliquefrance.fr\/beh\/2016\/35-36\/2016_35\u201336_3.htm."},{"issue":"1","key":"4213_CR28","doi-asserted-by":"publisher","first-page":"14152","DOI":"10.1038\/s41598-021-93432-0","volume":"11","author":"S Czernichow","year":"2021","unstructured":"Czernichow S, Renuy A, Rives-Lange C, Carette C, Airagnes G, Wiernik E, et al. Evolution of the prevalence of obesity in the adult population in france, 2013\u20132016: the Constances study. Sci Rep. 2021;11(1):14152. https:\/\/doi.org\/10.1038\/s41598-021-93432-0. PMID: 34238998; PMCID: PMC8266816.","journal-title":"Sci Rep"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04213-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04213-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04213-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T10:04:14Z","timestamp":1751364254000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-025-04213-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4213"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04213-0","relation":{"references":[{"id-type":"doi","id":"10.1038\/ki.2015.230","asserted-by":"subject"}]},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"26 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in the Constances study were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The National Data Protection Authority and the Institutional Review Board of the National Institute for Medical Research and the local Committee for Persons Protection approved the Constances study. All participants signed an informed consent to participate to the Constances epidemiologic cohort.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"JB reports, outside the submitted work, personal fees and\/or non-financial support from AstraZeneca, Bayer, Elkendi, Hikma, Leurquin, Omron, Organon, Sanofi, ViiV, Vivactis and Vivoptim. JMH reports, outside the submitted work, personal fees and\/or non-financial support from Ablynx, Alexion, AstraZeneca Rare Disease, AstraZeneca, Bayer, Bouchara-Recordati, Fresenius, GlaxoSmithKline, Mundipharma, Merck Sharp & Dohme, Roche, Servier, Sanofi, and Vifor Fresenius. The other authors have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"312"}}